Search - tctmd.com

Displaying 21 - 40 of 155

Sort: Relevancy | Date

News

Two siRNA Therapeutics Safely Lower Triglycerides in Mixed Hyperlipidemia

Michael O'Riordan

May 30, 2024

News Daily News

Less Is More: Lp(a) Much More Atherogenic Than LDL

Michael O'Riordan

January 16, 2024

News Daily News

Who Benefits Most From Semaglutide and How Long Will That Take?

Shelley Wood

December 19, 2023

News Daily News

Lp(a) Appears Tied to Myocardial Fibrosis: Observational Data

Yael L. Maxwell

December 13, 2023

News Daily News

Clopidogrel Bests Aspirin Monotherapy After PCI Across Risk Strata

Yael L. Maxwell

October 09, 2023

News Daily News

USPSTF: Screening Kids for Lipid Disorders Still Needs More Data

Shelley Wood

July 18, 2023

News Daily News

MI Risk in Subclinical CAD? Both Extent and Stenosis Severity Matter

Yael L. Maxwell

March 27, 2023

News Conference News ACC 2023

Treat to Target or With Intensity? Both Statin Tactics Cut MACE: LODESTAR

Michael O'Riordan

March 13, 2023

News Conference News ACC 2023

Clear CVD Benefit With Bempedoic Acid: CLEAR Outcomes

Michael O'Riordan

March 04, 2023

News Daily News

Zero CAC? LDL Cholesterol May Not Predict MI, ASCVD

Yael L. Maxwell

January 17, 2023

News Daily News

A Simple Nudge Moves the Needle on Statin Prescribing

Michael O'Riordan

December 02, 2022

News Daily News

Cardiac Biomarkers Reflect Sex Hormones in Transgender People

Caitlin E. Cox

October 06, 2022

News Daily News

New USPSTF Statin Guidance: Familiar Advice, Some Holes to Fill

Shelley Wood

August 23, 2022

News Daily News

FDA Plans to Slash Nicotine Levels in Cigarettes and Other Products

Michael O'Riordan

June 23, 2022

News Conference News EAS 2022

FH Patients Face Unchanging Acute MI Risks Plus Very Late Diagnoses

Michael O'Riordan

May 26, 2022

News Daily News

Good News and Bad for High-Intensity Statin Use in ASCVD

Michael O'Riordan

May 05, 2022

News Daily News

CVD Hospitalizations Spiked in Aftermath of 2020 US Election

Michael O'Riordan

April 22, 2022

News Conference News ACC 2022

APOLLO: Novel siRNA Injectable Cuts Lp(a) by Nearly 100% in Small Study

Michael O'Riordan

April 03, 2022

News Daily News

Clopidogrel Superior to ‘Divine’ Aspirin Monotherapy in Secondary Prevention

Michael O'Riordan

March 30, 2022

News Daily News

Icosapent Ethyl Cost-effective Compared With Standard Care: REDUCE-IT

Yael L. Maxwell

February 17, 2022

Advertisement

Two siRNA Therapeutics Safely Lower Triglycerides in Mixed Hyperlipidemia

Less Is More: Lp(a) Much More Atherogenic Than LDL

Who Benefits Most From Semaglutide and How Long Will That Take?

Lp(a) Appears Tied to Myocardial Fibrosis: Observational Data

Clopidogrel Bests Aspirin Monotherapy After PCI Across Risk Strata

USPSTF: Screening Kids for Lipid Disorders Still Needs More Data

MI Risk in Subclinical CAD? Both Extent and Stenosis Severity Matter

Treat to Target or With Intensity? Both Statin Tactics Cut MACE: LODESTAR

Clear CVD Benefit With Bempedoic Acid: CLEAR Outcomes

Zero CAC? LDL Cholesterol May Not Predict MI, ASCVD

A Simple Nudge Moves the Needle on Statin Prescribing

Cardiac Biomarkers Reflect Sex Hormones in Transgender People

New USPSTF Statin Guidance: Familiar Advice, Some Holes to Fill

FDA Plans to Slash Nicotine Levels in Cigarettes and Other Products

FH Patients Face Unchanging Acute MI Risks Plus Very Late Diagnoses

Good News and Bad for High-Intensity Statin Use in ASCVD

CVD Hospitalizations Spiked in Aftermath of 2020 US Election

APOLLO: Novel siRNA Injectable Cuts Lp(a) by Nearly 100% in Small Study

Clopidogrel Superior to ‘Divine’ Aspirin Monotherapy in Secondary Prevention

Icosapent Ethyl Cost-effective Compared With Standard Care: REDUCE-IT

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content